Related Experiment Video
Updated: May 1, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Obestatin: is it really doing something?
Letizia Trovato1, Davide Gallo, Fabio Settanni
1Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
Obestatin, a ghrelin-associated peptide, has controversial roles in appetite and metabolism. Emerging evidence suggests it may act as a hormone with diverse cellular and systemic effects, though its receptor remains debated.
Area of Science:
- Endocrinology
- Molecular Biology
- Gastroenterology
Background:
- Obestatin, identified in 2005, is derived from the prepro-ghrelin gene.
- Initial reports linked obestatin to G-protein-coupled receptor GPR39, reduced food intake, and gastric emptying, but these findings are debated.
- The precise receptor and physiological functions of obestatin are still under investigation.
Purpose of the Study:
- To review the current understanding of obestatin's physiological role.
- To discuss the ongoing debate regarding its receptor and effects on feeding behavior.
- To explore obestatin's broader cellular and metabolic functions.
Main Methods:
- Literature review of studies on obestatin.
- Analysis of research investigating obestatin's receptor interactions.
- Examination of data on obestatin's effects on cellular functions and metabolism.
Main Results:
- Obestatin's role in appetite regulation and gastric emptying remains controversial.
- Potential interaction with the glucagon-like peptide 1 receptor is suggested, alongside metabolic benefits.
- Obestatin exhibits cellular effects including regulation of metabolism, proliferation, and apoptosis inhibition.
- Obestatin is produced in the gastrointestinal tract, pancreas, and adipose tissue, acting both locally and centrally.
Conclusions:
- Obestatin exhibits diverse cellular and metabolic effects, suggesting a potential hormonal role.
- Further research is necessary to elucidate obestatin's precise physiopathological functions and confirm its receptor.
- Clarifying obestatin's actions is crucial for understanding its contribution to metabolic and gastrointestinal health.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Allosteric Regulation
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of Food Intake
Regulation of Metabolism
Feedback Inhibition

